Researchers sought to determine whether triglyceride levels were independently associated with cardiovascular disease among patients with coronary artery disease and type 2 diabetes.
Children who received a new diagnosis of type 1 diabetes during the COVID-19 pandemic are presenting with higher rates of diabetic ketoacidosis than in the previous 2 years.
Researchers used electronic health records to further understand the clinical features and gaps in treatment approaches for patients with severe hypercholesterolemia.
The use of intensive lifestyle intervention for weight loss in patients with type 2 diabetes has been shown to reduce the overall severity of obstructive sleep apnea.
Several companies have initiated recalls of metformin extended-release tablets due to the possibility of unacceptable levels of N-Nitrosodimethylamine, a probable human carcinogen.
For COVID-19 patients without a previous diagnosis of diabetes, fasting blood glucose (FBG) ≥7.0 mmol/L is an independent predictor of 28-day mortality.
Amino acid dysmetabolism can be detected during the early postpartum period and is predictive of the transition from gestational diabetes to type 2 diabetes.
A consensus statement outlines the benefits and barriers associated with diabetes self-management education and support (DSMES) in adults with type 2 diabetes.
Researchers implemented an electronic medical record-based depressive symptom screen in type 1 diabetes mellitus adolescents seen in an outpatient clinic.
Researchers analyzed diabetes mobile applications to evaluate patient self-management capabilities and the compliance of these apps with diabetes care guidelines.
Medical societies from the United Kingdom, Canada, and Australia have released recommendations for modification of testing during the COVID-19 pandemic.
